key: cord-1049910-1q079br3
authors: Cenac, C.; Ducatez, M.; Guery, J.-C.
title: Hydroxychloroquine inhibits proteolytic processing of endogenous TLR7 protein in human primary plasmacytoid dendritic cells
date: 2021-09-22
journal: nan
DOI: 10.1101/2021.09.14.21263569
sha: 5645b3b86be245411d4864a649f8ebb34b38136d
doc_id: 1049910
cord_uid: 1q079br3

Toll-like receptor 7 (TLR7) triggers antiviral immune responses through its capacity to recognize single-stranded RNA. Proteolytic cleavage of TLR7 protein is required for its functional maturation in the endosomal compartment. Structural studies demonstrated that the N- and C-terminal domains of TLR7 are connected and involved in ligand binding after cleavage. Hydroxychloroquine (HCQ), an antimalarial drug, has been studied for its antiviral effects. HCQ increases pH in acidic organelles and has been reported to potently inhibit endosomal TLR activation. Whether HCQ can prevent endogenous TLR7 cleavage in primary immune cells, such as plasmacytoid dendritic cells (pDCs), had never been examined. Here, using a validated anti-TLR7 antibody suitable for biochemical detection of native TLR7 protein, we show that HCQ-treatment of fresh PBMCs, CAL-1 leukemic and primary human pDCs inhibits TLR7 cleavage and results in accumulation of full-length protein. As a consequence, we observe an inhibition of pDC activation in response to TLR7 stimulation with synthetic ligands and viruses including inactivated SARS-CoV2, which we show herein activates pDCs through TLR7-signaling. Together, our finding suggests that the major pathway by which HCQ inhibits ssRNA-sensing by pDCs may rely on its capacity to inhibit endosomal acidification and the functional maturation of TLR7 protein.

The Toll-like receptor 7 (TLR7) is essential for the induction of antiviral immunity but is also involved in the pathogenesis of systemic lupus erythematosus (SLE), an autoimmune disease with a strong female bias [1, 2] . TLR7 is a single-stranded RNA receptor encoded by an X-linked gene, and is maintained under strong purifying selection, which attests to nonredundant vital functions [3] . However, rare TLR7 genetic variants suppressing or modifying the function of the receptor have been recently identified in young male patients associated with severe COVID-19 [4] .

TLR7 is expressed primarily in plasmacytoid dendritic cells (pDCs), B lymphocytes and monocytes [5, 6] . TLR7 protein exists in full size 140 kDa form in the endoplasmic reticulum (ER) and then undergoes post-ER proteolysis at the leucine-rich repeat (LRR) LRR14 and LRR15 regions, resulting in a C-term fragment of 75 kDa [7] . Crystallographic analysis of TLR7 shows that the C-term fragment remains associated with the N-term part of TLR7 to form a functional receptor in endosomes with two binding sites one for guanosine and another for ssRNA polyuridines [8] .

Chloroquine (CQ) and hydroxychloroquine (HCQ) are used as first-line of treatment in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis, and have been shown to prevent endosomal TLR activation and type I IFN production by pDCs [9] . The ability of these drugs to inhibit activation of Toll-like receptors (TLR9, TLR8, and TLR7) has been attributed to their capacity to interact with nucleic acid ligands [10] , rather than to the inhibition of endosome acidification, which is necessary for the maturation of these receptors [11, 12] .

Conflicting results exist regarding the contribution of acid-dependent protease activity in the processing of endosomal TLR7 between mouse and human. Study in mouse cells have reported that processing of TLR7 and TLR9 does not take place in the absence of acidification of the All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 22, 2021. ;  https://doi.org/10.1101/2021.09.14.21263569 doi: medRxiv preprint endolysosomal compartments and requires stepwise processing with proteases [7, 13] . By contrast, processing of human TLR7 has been reported to be mediated by furin-like proteases at neutral pH, suggesting differential requirement for TLR7 processing between human and mouse [14] . So far, assessment of the effect of inhibition of endosomal acidification by HCQ or bafilomycin A1 on endogenous TLR7 cleavage in primary human immune cells has not been examined due to the lack of suitable antibodies for biochemical detection of TLR7.

In the present study, we investigated the impact of HCQ on the processing of human endogenous TLR7 in whole PBMCs, in the leukemic pDC line CAL-1, as well as in primary human pDCs using a highly-specific anti-TLR7 antibody [6, 15] . We also measured the halflife of TLR7 and the impact of HCQ on pDC activation in response to synthetic TLR ligands, as well as viruses, including SARS-CoV2.

Inhibition of endosomal acidification in fresh PBMCs inhibits TLR7 cleavage and results in accumulation of full-length protein. Analysis of human TLR7 protein expression in primary cells has been hampered due to the lack of suitable specific antibodies. We recently validated a commercially available monoclonal antibody directed against the C-terminus of human TLR7 that correctly detected both the full-length (140 kDa) and proteolytically mature (75 kDa) forms of natural and recombinant TLR7 in immunoblot analysis of human PBMCs [6, 15] (Fig. 1A-B) . We investigated the impact of 18 hour-HCQ exposure of fresh PBMCs on TLR7 protein cleavage. We observed by immunoblot a dose dependent inhibition in the accumulation of the truncated 75 kDa C-term form of TLR7, which was concomitantly associated with an enhanced expression of the full-length 140 kDa TLR7 protein (Fig. 1C) . As a consequence, the ratio between the full length versus truncated form of TLR7 was reduced for HCQ concentrations from 5 to 15 µM. As expected, blockade of autophagy by HCQ resulted in accumulation of LC3-II (Fig. 1D) . Interestingly, similar results were observed using bafilomycin A1, an inhibitor of the vacuolar H + -ATPase which blocks acid-dependent protease activity ( Fig. 1E-G) . Overnight incubation of fresh PBMCs with bafilomycin A1 at low doses ranging from 50 to 100 nM inhibited by more than 70% the expression of the cleaved 75 kDa form of human TLR7 (Fig. 1E-G) . Thus, endosomal acidification is critical for processing of endogenous TLR7 in human PBMCs.

HCQ inhibits TLR7 processing in human leukemic and primary pDCs. We first estimated the half-life of TLR7 protein in the leukemic CAL-1 pDC cell line. CAL-1 cells were exposed to cycloheximide (CHX) and then collected at different time points to quantify the proportion of the full-length and the processed forms of TLR7 relative to total protein levels ( Fig. 2A-B) . CHX-treatment resulted in a rapid decline in the relative proportion of both 140 kDa and 75 kDa TLR7 proteins in CAL-1 cells. From these results, we estimated the half-life of TLR7 protein to be in the range of 4 to 6 hours. These results indicate that TLR7 mRNA is constitutively translated into full-length TLR7 protein in CAL-1 cells probably as a consequence of constitutive expression of TLR7 mRNA transcripts in pDCs at single cell resolution [15, 16] . These results also show that the functionally active processed form of TLR7 follows the same kinetics, suggesting that continuous processing of TLR7 is required for its accumulation and activity in endosomes [14] . perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in To confirm that TLR7 processing occurs in an acidic environment in human pDCs, we measured the impact of bafilomycin A1 on TLR7 cleavage in CAL-1 cells. Bafilomycin A1 has been reported to prevent TLR9 receptor proteolysis, resulting in accumulation of full-length protein [7] . We show that 250 nM of bafilomycin leads to an almost complete inhibition of TLR7 cleavage which correlated to an accumulation of LC3-II ( Fig. 2E -F) , and was detected as soon as 2 to 4 hours of incubation with either HCQ or bafilomycin A1 (Supporting information Fig. S1 ). These results suggest that processing of endogenous TLR7 is a continuous process occurring in the endosomal acidic compartment in the leukemic CAL-1 pDC cell line, in agreement with published results regarding TLR9 processing [7] .

To assess the impact of HCQ on endogenous TLR7 cleavage in primary human pDCs, we used an in vitro assay where human primary pDCs were cultured in the presence of IL-3 [17] . As for the CAL-1 cells, we found that 18 hour-treatment of primary IL-3-pDCs with HCQ resulted in significant inhibition of TLR7 processing at concentrations ranging from 5 to 1.25 µM of HCQ ( Fig. 2G-H) . Again, we observed a strong correlation between accumulation of LC3-II in HCQ-treated IL-3-pDCs and the dose-dependent inhibition in the accumulation of the C-term 75 KDa truncated form of TLR7 ( Fig. 2G-H) . Together, these results show that in leukemic CAL-1 cells and in primary human pDCs, HCQ can prevent the proteolytic cleavage of TLR7 protein.

established that TLR7 processing is required for functional activity, we evaluated the impact of HCQ treatment on proximal signaling events in CAL-1 cells stimulated with imiquimod.

Immunoblots were used to evaluate the phosphorylation of IRAK1, Akt and p38 as well as the degradation of IkBa (Supporting information Fig. S2A ). IRAK1 phosphorylation by IRAK4 recruited to Myd88 is an early event of TLR7-activation leading to IRF7 activation and type I IFN production in pDCs [18] . As early as 30 minutes after TLR7 stimulation we observed a All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.14.21263569 doi: medRxiv preprint defect in IRAK1 phosphorylation in HCQ treated cells compared to untreated cells, which was maintained at 60 minutes (Supporting information Fig. S2A -B). We observed a similar profile for the imiquimod-induced phosphorylation of Akt and p38-MAPK (Supporting information Fig. S2C -D, respectively). Moreover, altered degradation of IkBa after HCQ treatment was also observed pointing to a general defect in TLR7-signaling in HCQ-treated cells (Supporting information Fig. S2E ). At steady state, expression of these downstream signaling proteins, including IRF7, was not affected by HCQ-treatment nor cell-viability (Supporting information 

HCQ treatment. As HCQ downregulates TLR7-dependent proximal signaling, we analyzed the impact of HCQ treatment on the capacity of IL-3-pDCs to produce IFN-a, IP-10 and TNFa in response to activation with TLR7 ligands, including viruses. As in Fig. 2G , IL3-pDCs were incubated for the last 18 hours with various concentrations of HCQ before assessment of their functional responses. As shown in Fig. 3 and Supporting information Fig. S4 , an almost complete inhibition of cytokine production was found for all doses of HCQ tested including the lowest one upon stimulation with the TLR7/8 ligand CL097. A similar trend was observed when pDCs were stimulated with betapropiolactone (BPL)-inactivated influenza A/Puerto Rico/8/1934(H1N1) virus (PR8) and BPL-inactivated Occitanie/2020/SCoV2-006 (SARS-CoV2) (Fig. 3 B-C) . Likewise, the response of IL-3-pDCs stimulated through TLR9 with CpG-C was also totally inhibited upon HCQ treatment (Supporting information Fig. S4G ). This inhibitory action of HCQ was not associated with enhanced cell death or apoptosis within the dose-range tested, and HCQ-treated IL-3-pDCs were still able to produce large amounts of TNF-a when activated with PMA and ionomycin (Supporting information Fig. S4H -I).

Our results confirmed recent observations that SARS-CoV2-induced pDC activation can be inhibited by HCQ [19] . Using genetically deficient patients, it was reported that pDC All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.14.21263569 doi: medRxiv preprint activation was critically dependent on IRAK4 and UNC93B1 [19] . However, because these genes can control the endosomal responses mediated by TLR7, TLR8 and TLR9, the exact nature of the TLR involved in pDC activation by SARS-CoV2 was unclear. As SARS-CoV2 is a ssRNA virus, we assess the role of TLR7 using mice deficient for this TLR. As shown in Fig.   3D and Supporting information Fig. S4 , BPL-inactivated SARS-CoV2 readily activates the production of IFN-a, IL-12p40 or TNF-a in bone marrow pDCs from wild type but not in pDCs from TLR7-deficient mice. As a control, the TLR9-dependent response to CpG-A stimulation was preserved in TLR7-deficient animals (Fig. 3E, Supporting information Fig. S4 ). Thus, in response to inactivated SARS-CoV2, activation of pDC innate function is exclusively mediated through TLR7 signaling.

This study reveals that the half-life of TLR7 protein is relatively short in human pDCs and requires continuous translation to maintain suitable processed TLR7 receptor for functional activation. Because of this short half-life, blockade of TLR7 processing with the drug HCQ or bafilomycin A1 rapidly results in the reduction in the functionally active form of the protein in the CAL-1 pDC cell line, but also in primary human pDCs. We now provide strong evidence that acid-dependent protease activity is critical for endogenous TLR7 processing in human pDCs, contrary to previous observations in TLR7-transduced THP-1 monocyte cell line [14] .

Of note, cleavage inhibition of endogenous TLR7 was also evident in fresh PBMCs after 18 hours incubation with HCQ or bafilomycin A1 suggesting that acid-dependent endosomal proteases are critical for endogenous TLR7 processing across various cell types, including monocytes and B cells. Indeed, deconvolution experiments regarding the source of TLR7 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.14.21263569 doi: medRxiv preprint expression by human PBMCs revealed that monocytes, pDCs and B cells were the main contributors of TLR7 protein expression at steady state [6] .

Our results add to the list of the off-target effects of HCQ as an anti-viral drug [9] . Early activation of TLR7-dependent innate immunity is likely critical to control SARS-CoV2 infection as revealed by the occurrence of severe COVID-19 in patients with inborn errors of immunity targeting the type I IFN [20] or TLR7 [4] pathways. We propose that the anti-viral properties of HCQ could be counterbalanced by its capacity to blunt protective immunity linked to TLR7 activation or other immunomodulatory mechanisms [9] . This may contribute to explain the lack of beneficial action of HCQ in vivo on COVID-19 [21, 22] or SARS-CoV2 infection in non-human primates [23] . Indeed, in vivo treatment with HCQ in SLE patients has been shown to inhibit TLR7 and TLR9-dependent activation of pDCs upon ex vivo exposure of pDCs with specific TLR ligands [24] . Moreover, SLE patients with long-term treatment with HCQ are not protected from severe COVID-19 [25] .

Our finding suggests that the major pathway by which HCQ inhibits TLR7-signaling may rely on its capacity to inhibit endosomal pH acidification thereby blunting the functional maturation of TLR7 protein. However, we cannot rule out that inhibition of interactions between TLR and nucleic acids [10] could be an additional mechanism of action of HCQ, particularly for TLR9, which has been reported to be more sensitive than TLR7 pathway for HCQ-mediated inhibition of pDC innate function in vivo [24] . Whether HCQ protection in SLE is associated with inhibition of proteolytic cleavage of endosomal TLRs will warrant further investigations.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.14.21263569 doi: medRxiv preprint

The CAL-1 human pDC cell line [26] was grown in R10 media which is: complete RPMI 1640 medium supplemented with 2 mM L-Glutamine, 1 mM sodium pyruvate, 100 U/mL penicillin/streptomycin, non-essential ammino acids, 50 µM 2-ME (all from Invitrogen) to which 10 % heat inactivated fetal bovine serum (Sigma) was added. Cells were cultured at 37°C in a CO2 in air incubator. Cells were seeded into 24-well plates (1 x 10 6 cells / well) and 

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.14.21263569 doi: medRxiv preprint

supplemented with 100 U/mL penicillin, 100 μg/ml streptomycin (Invitrogen), and 1 µg/ml TPCK trypsin. SARS-CoV2 was grown on Vero E6 cells (ATCC) in DMEM (Dutscher) supplemented with 100 U/mL penicillin, 100 μg/ml streptomycin (Invitrogen), and 2% heat inactivated fetal bovine serum (Sigma). Viral stocks were propagated in 300 cm 2 flasks (Dutscher) on which 10 3 tissue culture infectious dose 50 (TCID50) of the respective viruses were inoculated in 100 ml infection media for 3 days at 37°C with 5% CO2. Each virus (culture supernatant) was harvested and inactivated with BPL (Fischer) overnight at 4°C. Each virus was concentrated by ultracentrifugation. Briefly, viral supernatant was transferred in Ultra-Clear centrifuge tubes (Beckman) on a 20% sucrose cushion. Then they were centrifuged at 4°C for 2 hours at 25 000 rpm using the Beckman SW-32 Ti rotor. Pellets were resuspended in PBS and stored at -80°C until use.

Male mice used were 18 weeks-old C57BL/6J (WT) or B6.129S1-Tlr7 tm1Flv /J (Jackson Laboratory). Animals were housed in specific pathogen-free conditions. All mice were handled according to the Animal Care and Use of Laboratory guidelines of the French Ministry of Research. Bone marrow cells were isolated by flushing femurs with RPMI. Cells were seeded in 24-well plates (5 x 10 6 cells / well) and stimulated with SARS-CoV2 (20 μg/mL) or Class A CpG, ODN 1585 (20 µg/mL) (Invivogen) for 4 hours with Brefeldin A for the last 2 hours.

Cell lysates were prepared in Laemmli sample buffer (Invitrogen) and sonicated for 10 seconds.

Total protein was quantified by BCA Protein Assay Kit (Pierce). Samples were heated for 10 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.14.21263569 doi: medRxiv preprint (clone RA3-6B2, Invitrogen). For intracellular staining, cell were permeabilized in Perm/wash solution (BD Biosciences) and stained with : anti-IFNa-APC (clone RMMA-1, Invitrogen), anti-TNFa-PE (clone MP6-XT22, BD Biosciences), and anti-IL-12p40-PE-Cy5.5 (clone C17.8, Invitrogen). Samples were acquired on LSR II or Fortessa (BD Biosciences). The gating strategy is displayed as Supporting Information Fig. S4 and Fig. S5 .

FACS analyses were made by using FlowJo software v10 (TreeStar). Statistical analyses were carried out using GraphPad Prism 8 software (GraphPad). Statistical significance was analyzed using two-way ANOVA followed by Dunnett test.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 

No conflicts of interest, financial or otherwise, are declared by the authors.

The data that support the findings of this study are presented in this paper. No shared databases were used or created.

CC and JCG conceived and designed the study. CC performed experiments and analyzed the data. MD contributed essential reagents. JCG wrote the manuscript with input from the coauthors. All authors read and approved the final version of the manuscript.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.14.21263569 doi: medRxiv preprint perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.14.21263569 doi: medRxiv preprint two-way ANOVA followed by Dunnett test. Significance is indicated by *(p<0.05), **(p<0.01), ***(p<0.001), or ****(p<0.0001). (D, E) Bone marrow pDCs from wild type (black circles) or TLR7-deficient mice (open squares) were stimulated with inactivated SARS-CoV2 (D) or CpG-A (E). Histograms show the frequency of pDCs expressing the indicated cytokines after 4 hours of stimulation. Data are expressed as mean ± SEM of 3 to 4 different mice.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.14.21263569 doi: medRxiv preprint All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted September 22, 2021. ; https://doi.org/10.1101/2021.09.14.21263569 doi: medRxiv preprint

Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation

The multiple pathways to autoimmunity

Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense

Hagmolen Of Ten Have

RNA recognition by human TLR8 can lead to autoimmune inflammation

TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in women

Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase

Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA

Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine

Processing of human toll-like receptor 7 by furin-like proprotein convertases is required for its accumulation and activity in endosomes

TLR7 escapes X chromosome inactivation in immune cells

Heterogeneous Escape from X Chromosome Inactivation Results in Sex Differences in Type I IFN Responses at the Single Human pDC Level

Systematic cytokine receptor profiling reveals GM-CSF as a novel TLR-independent activator of human plasmacytoid predendritic cells

Regulation of TLR7/9 signaling in plasmacytoid dendritic cells

SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4

Hydroxychloroquine use against SARS-CoV-2 infection in nonhuman primates

Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine

A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma